Compare THM & INMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | THM | INMD |
|---|---|---|
| Founded | 1978 | 2008 |
| Country | Canada | Israel |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 723.2M | 842.0M |
| IPO Year | 2002 | 2018 |
| Metric | THM | INMD |
|---|---|---|
| Price | $2.35 | $13.74 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $16.75 |
| AVG Volume (30 Days) | ★ 1.2M | 998.4K |
| Earning Date | 05-08-2026 | 04-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $1.70 |
| Revenue Next Year | N/A | $3.99 |
| P/E Ratio | ★ N/A | $10.11 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.46 | $12.72 |
| 52 Week High | $3.65 | $16.74 |
| Indicator | THM | INMD |
|---|---|---|
| Relative Strength Index (RSI) | 46.85 | 51.22 |
| Support Level | $2.22 | $13.28 |
| Resistance Level | $3.63 | $13.87 |
| Average True Range (ATR) | 0.18 | 0.30 |
| MACD | 0.01 | 0.07 |
| Stochastic Oscillator | 61.64 | 84.76 |
International Tower Hill Mines Ltd is a mining company. It is engaged in the acquisition, exploration, and development of mineral properties. The company holds interests in an exploration project namely the Livengood Gold Project. It is located in northwest of Fairbanks, Alaska in the Tolovana mining district within the Tintina gold belt. The project property consists of land leased from the Alaska Mental Health Trust, several smaller private mineral leases, Alaska state mining claims purchased or located by the company, and the patented ground held by the company.
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF, and Morpheus8, among others. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia, Israel, and other regions.